• LifeStance Health entered into underwriting agreement with J.P. Morgan Securities for secondary offering of 35,000,000 shares of common stock sold by selling stockholders.
• Company agreed to repurchase 6,000,000 of those shares from underwriter at same per-share price paid to selling stockholders.
• Company received no proceeds from offering; underwriter received no compensation on shares repurchased by company.
• Offering closed May 12, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeStance Health Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-219669), on May 12, 2026, and is solely responsible for the information contained therein.